Email Address
(this will be your username)
Full Name
Password Confirm Password Contact Number Country
Vienna 2018 Congress Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Hotel Information

Thursday 20 September | 13:00 - 14:00

Lunchtime Symposia

Location: Room C1

DME Management: Optimising Real World Outcomes

Moderator(s): A. Loewenstein Israel F. Bandello Italy

M. de SmetThe Netherlands

In-clinic decision making: ’parameters to evaluate & signs to interpret’

A. Koh Singapore

Real life vs clinical trial: ‘a closer look’

Summary

J. Conrath France

Head to head: ‘comparing therapeutic options’

L. Kodjikian France

Individualised DME management: ‘tips and tricks’

Panel discussion and Q&A

Location: Room D2

Clinical Advances and Applications with Swept Source OCT & Angiography

Moderator(s): J.M. Ruiz-Moreno Spain

J.M. Ruiz-Moreno Spain

SS OCT Angio in the diagnostic of pre-oftalmoscopic diabetic retinopathy

C. Hoyng The Netherlands

Vascular flow changes in macular telangiectasia type 2 in OCT-A

L. Pierro Italy

OCT-A in optic nerve pathology

P. Keane UK

SS OCT Angio in proliferative diabetic retinopathy

Location: Lehar 1

Photobiomodulation: An Innovative, Mitochondria-targeted Therapy for Dry AMD and Other Ocular Diseases

Moderator(s): J. Eells USA M. Munk Switzerland

J. Eells USA

Overview of the mechanism and application of PBM in retinal disease

K. Valter Australia

From bench to bedside – PBM in preclinical studies

S. Markowitz Canada

LIGHTSITE I Clinical analysis of the safety and efficacy of photobiomodulation in subjects with dry age-related macular degeneration

M. Munk Switzerland

Morphological analysis: evaluating the impact of photobiomodulation using multimodal imaging description

Friday 21 September | 10:00 - 11:00

Morning Symposia

Location: Room C1

Lessons Learned from the Real World: Improving Patient Care

Moderator(s): J-F. Korobelnik France

J-F. Korobelnik France

Welcome and Introductions

A. Tufail UK

RWE: evolution of a key information source

P. Kaiser Australia

Focus on aflibercept: the latest evidence from clinical practice

J-F. Korobelnik France

P. Kaiser USA

A. Tufail UK

P. Mitchell Australia

Consider the clinic: Improving practice with RWE

J-F. Korobelnik France

Summary

Location: Room D1

Seeing the Future: Gene Therapy for Inherited Retinal Disease

Moderator(s): C. Fasser Switzerland B. Leroy Belgium

D. Fischer Germany

Understanding inherited retinal diseases from a clinician and patient perspective

I. Audo France

The importance of genotyping: who, how and why?

B. Leroy Belgium

Great expectations: exploring recent innovations in gene therapy

Q&A

Location: Room D1

The OCTA Trinity

Moderator(s): D. Pauleikhoff Germany

K. Freund USA

Dense B-Scan OCTA in AMD

D. Pauleikhoff Germany

OCTA in AMD

A. Pollreisz Austria

OCTA in vascular diseases

Friday 21 September | 13:00 - 14:00

Lunchtime Symposia

Location: Room C3

Continuous Microdosing with ILUVIEN: Optimising the Treatment of Persistent or Recurrent DME

Moderator(s): F. Bandello Italy

M. Falcão Portugal

When first-line treatments fail in DME

J. Zarranz-Ventura Spain

Inflammation and the role of steroids for the treatment of DME

A. Augustin Germany

3 years of ILUVIEN; real-world data from Germany and the UK

Location: Room C2

Proactive Dosing for Effective Patient Management: What do the Latest Data Show?

Moderator(s): P. Lanzetta Italy

P. Lanzetta Italy

Welcome and Introductions

P. Kaiser USA

Proactive dosing with aflibercept

G. Cheung Singapore

T&E with aflibercept: updates from ALTAIR

P. Mitchell Australia

T&E with aflibercept: updates from ARIES

P. Lanzetta Italy

P. Kaiser USA

G. Cheung Singapore

P. Mitchell Australia

Staying ahead of retinal disease: the importance of a proactive approach

P. Lanzetta Italy

Summary

Location: Room C4

Ranibizumab- New Evidence; New Insights:
Partnering for Better Patient Outcomes

Moderator(s): N. Eter Germany

N. Eter Germany

Welcome

N. Eter Germany

Ranibizumab in retinal diseases: looking beyond the decade...

R. Tadayoni France

Clinical cases: the experts’ viewpoint - clinical case I

P. Schlottmann Argentina

Clinical cases: the experts’ viewpoint - clinical case II

A. Koh Singapore

Clinical cases: the experts’ viewpoint - clinical case III

Panel Discussion

N. Eter Germany

Summary and Close

Location: Room D1

200° Ultra-Widefield Retinal Imaging: Clinical Advances And Emerging Applications

Moderator(s): L. Aiello USA

L. Aiello USA

Potential impact of ultra-widefield imaging on diabetic retinopathy severity grading and clinical follow-up intervals

S. Sadda USA

Clinical impact of a combined UWF imaging and OCT device

T. Peto UK

Ultra-widefield imaging in dementia

R. Tadayoni France

Location: Room D5

Illuminating the future of DME management

Moderator(s): N. Bressler USA

N. Bressler USA

Opening remarks

R. Tadayoni France

Approaches to managing the unmet needs in DME

A. Loewenstein Israel

Molecular mediators in the pathophysiology of DME

P. Dugel USA

Broadening the DME treatment landscape: novel therapeutic approaches on the horizon

Panel discussion

Location: Room D2

Understanding and Measuring Functional Loss in Macular Disease: Multimodal Diagnostics

Moderator(s): U. Schmidt-Erfurth Austria

U. Schmidt-Erfurth Austria

Functional loss in GA

R. Abreu Gonzalez Spain

Wide field OCT-A and retinal functional assessment with microperimetry in clinical practice

S. Sadda USA

OCT-A quantitative assessments of the choriocapillaris: new insights in AMD

Q&A

Saturday 22 September | 10:00 - 11:00

Morning Symposia

Location: Room C3

Fusing technologies into integrated solutions for every Vitreoretinal Surgery

Moderator(s): R. Tadayoni France

R. Tadayoni France

Introduction and opening remarks

K. Al Sabti Kuwait

NGENUITY® and CONSTELLATION® integration: elevating vitreoretinal surgeries

D. Chow Canada

The evolving science behind NGENUITY® 3D visualization system

C. Claes Belgium

New possibilities in complex vitreoretinal surgeries

S. Rizzo Italy

Enhancing 27+® gauge vitreoretinal surgeries with the latest product innovations and techniques

Panel discussion

Location: Room C1

Changing the Course: Disease Modification with Intensive Early Treatment for DME

Moderator(s): I. Pearce UK

I. Pearce UK

Welcome and introductions

N. Bressler USA

Improving quality of life with diabetes: striving for excellent vision

I. Pearce UK

Delve into the design: the multitargeted MoA of aflibercept

E. Midena Italy

Examine the evidence: aflibercept in DME

N. Bressler USA

Choice of anti-VEGF and treatment regimen: clinically relevant insights from the DRCR Network

I. Pearce UK

Summary and questions

Location: Room C4

Retinal Disease Management: Transferring Bench to Bedside

Moderator(s): A. Loewenstein Israel

J. Zarranz-Ventura Spain

Interpreting diagnostic drivers

B. Kupperman USA

Safety of steroids: evidence explained

C. Busch Germany

DME: treat, switch, operate or refer

J. Chhablani India

Ozurdex: learning from evidence

M. Goldstein Israel

Practical decision making in DME: a clinician’s perspective

Panel discussion and Q&A

Location: Room D2

SubLiminal Laser Therapy: When Subthreshold Laser Yields Good Macular Outcomes

Moderator(s): V. Chong UK

V. Chong UK

SubLiminal laser in macular diseases

S. Younis UK

Efficacy of SubLiminal laser in IPCV aflibercept resistant cases

A. Filloy Spain

Our first year of lessons learnt with SubLiminal laser for DME and CSC

L. XiaoLing China

Conventional threshold laser vs SubLiminal laser in CSC

Location: Room D4

Complement C3 Inhibition in Geographic Atrophy

Moderator(s): J. Slakter USA

F. Grossi USA

Welcome and introduction to Apellis

U. Chakravarthy UK

Disease burden in geographic atrophy

P. Rosenfeld USA

Complement activation in geographic atrophy and APL-2 mechanism of action

F. Holz Germany

FILLY phase 2 results and phase 3 study design

J. Slakter USA

Panel Discussion

Saturday 22 September | 13:00 - 14:00

Lunchtime Symposia

Location: Room D4

Innovations to Inspire New Surgical Techniques

Moderator(s): J. van Meurs The Netherlands

M. Romano Italy

Fluid dynamics with a hypersonic probe: balance between acceleration and flow

Y. Le Mer France

Vitreous removal with Stellaris Elite™: from cutting to liquefaction

F. Fayyad Jordan

Management of complex cases using a complete 27 gauge portfolio

Location: Room C4

Advancing Therapy for nAMD

Moderator(s): U. Schmidt-Erfurth Austria

U. Schmidt-Erfurth Austria

Welcome and introduction

A. Loewenstein Israel

nAMD: challenges and opportunities for disease management

F. Holz Germany

Therapeutic innovations for nAMD

P. Dugel USA

Advanced clinical development programs for nAMD: new potential for disease control

Panel Discussion and Q&A

Location: Room D1

2RT for Early AMD: The Role of Nanosecond Laser Therapy

Moderator(s): U. Chakravarthy UK

R. Guymer Australia

J. Marshall UK

R. Finger Germany

Location: Room D2

How can Innovation Deliver Real Benefits to Improve VR Surgery?

Moderator(s): P. Stalmans Belgium

J. Fortun USA

How more options in fluidics can benefit complex cases

P. Stalmans Belgium

How my preferred VR system just got better!

R. Avci Turkey

Why instrument innovations give more options for my complex VR surgery

M. Romano Italy

Why surgical liquids purity matters?

Location: Room C3

Breaking News in Retina

Moderator(s): T. Aslam UK

R. Avci Turkey

OCT angiography of the retina

A. Minnella Italy

How to identify patients at risk of AMD in routine clinical practice?

A. Garcia Layana Spain

New trends in AMD prevention

T. Aslam UK

Patient well-being in AMD

Location: Room D5

Complete Retinal Imaging Platform - A View into Integrating WideField Fundus and OCT-A

Moderator(s): J-F. Korobelnik France

J-F. Korobelnik France

Integrated diagnostic imaging (IDI)

G. Lang Germany

Zeiss AngioPlex update

G. Querques Italy

Swept Source OCT - Zeiss PlexElite